KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Authorities in health sectors within the Democratic Republic of the Congo have launched a targeted Ebola vaccination effort in Kisangani, the administrative center of Tshopo Province, aiming to control the country’s most severe outbreak of the disease to date. Frontline healthcare providers, emergency responders, and individuals with direct exposure to confirmed cases are being prioritized during the initial rollout. Health Minister Roger Kamba confirmed that the government has initiated the immunization campaign using doses of the Ervebo vaccine to protect frontline workers operating across the affected eastern regions.
Official epidemiological figures show that the ongoing outbreak has expanded across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Data released by the Ministry of Public Health and Prevention reveal that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current case fatality rate among confirmed cases is approximately 48%.
The health emergency has prompted international agencies, including the World Health Organization, to assist local health teams with logistics, laboratory testing, and distribution of vaccines. Authorities are administering the Ervebo vaccine under a compassionate-use protocol while researchers gather observational data on its effectiveness against the circulating viral strain. DR Congo’s Ebola vaccination efforts include ring-vaccination strategies around identified infection clusters to interrupt transmission chains.
DR Congo Initiates Ebola Vaccination Rollout in Affected Eastern Regions
Operational challenges persist due to complex regional infrastructure, ongoing security issues, and high population movement across border areas. Cold-chain logistics have been set up in Kisangani to preserve the ultra-cold temperatures necessary for vaccine storage before distribution to outlying health zones. DR Congo launches Ebola vaccination campaign while civil defense and community health workers conduct outreach to improve disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are collaborating with local teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials stress that early clinical detection, combined with isolation and supportive treatment, remains vital for improving patient survival. Additional vaccine supplies are expected as regional distribution expands to secondary health districts.
Kisangani Acts as Central Hub for Vaccine Logistics in the Region
National teams continue to broaden contact-tracing efforts across urban and rural areas in the eastern part of the country. Local health centers are supplied with personal protective equipment, diagnostic reagents, and therapeutic resources to boost readiness. Government agencies confirmed that comprehensive public health measures will stay in place until transmission rates show consistent decline across all affected provinces.
The government has called on local communities to fully cooperate with mobile vaccination units and follow sanitary protocols. It is expected that higher immunization coverage among high-risk populations will help stabilize infection levels in the coming weeks. Surveillance systems will continue heightened monitoring at transportation hubs and border crossings to prevent further spread.